Formulation and evaluation of rizatriptan Benzoate mouth disintegrating tablets

Indian Journal of Pharmaceutical Sciences

Volumn 72, Issue 1, 2010, Pages 79-85

  Keny, R V ^a   Desouza, Chrisma ^a   Lourenco, C F ^a  

^a GOA COLLEGE OF PHARMACY   (India)

Author keywords

Direct compression; In vitro and in vivo disintegration time; Mouth disintegrating; Rizatriptan benzoate; Wetting time

Indexed keywords

AMERICAN MINT DC 213; ASPARTAME; CARBOXYMETHYLCELLULOSE; CROSPOVIDONE; EXCIPIENT; INDION 234; INDION 414; MAGNESIUM STEARATE; MANNITOL; MICROCRYSTALLINE CELLULOSE; RIZATRIPTAN; TALC; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG RELEASE; DRUG STABILITY; MOUTH DISINTEGRATING TABLET; TABLET COMPRESSION; TABLET DISINTEGRATION; TABLET DISINTEGRATION TIME; TABLET FORMULATION; TABLET FRIABILITY; TABLET HARDNESS; TABLET MANUFACTURE; TABLET PROPERTY; TABLET THICKNESS; TABLET WEIGHT; WETTABILITY;

EID: 77951672744     PISSN: 0250474X     EISSN: 19983743     Source Type: Journal    
DOI: 10.4103/0250-474X.62253     Document Type: Article

References (22)

1. Sanders-Bush E, Mayer SE. 5-hydroxytryptamine (Serotonin): Receptor agonists & antagonists. In: Brunton LL, Lazo JS, Parker KL, editors. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 11th ed. New York: McGraw Hill; 2006. p. 305-309
2. Antimigraine Drugs. In: Sweetman SC, editor. Martindale the complete drug reference. 33rd ed. London: Pharmaceutical Press; 2002. p. 445-446
3. Malke S, Shidhaye S, Kadam VJ. Formulation and evaluation of oxcarbazepine fast dissolve tablets. Indian J Pharm Sci 2007;69:211-214
4. Sastry SV, Nyshdham JR, Fix JA. Recent technological advances in oral drug delivery: A review. Res Focus Pharma Technol 2000;3:138-145
5. Kaushik D, Dureja H, Saini TR. Formulation and evaluation ofolanzapine mouth dissolving tablet by effervescent formulation approach. Indian Drugs 2004;41:410-412
6. Kuchekar BS, Badhan AC, Mahajan HS. Mouth dissolving tablets: A novel drug delivery system. Pharma Times 2003;35:7-9.
7. Redkar MR, Gore SP, Devrajan PV. D-Zolv: Taste masked mouth dissolving tablet. Indian J Pharm Sci 2002;64:291-292
8. Chang R, Guo X, Burnside B, Couch R. A review of fast dissolving tablets. Pharm Tech North Am 2000;12:52-58
9. Bi Y, Sunada H, Yonezawa Y, Danjo K, Iida K. Preparation and evaluation of compressed tablets rapidly disintegrationg in the oral cavity. Chem Pharm Bull 1996;44:2121-2127
10. Kuchekar BS, Badhan AC, Mahajan HS. Mouth dissolving tablets of salbutamol sulphate: A novel drug delivery system. Indian Drugs 2004;41:592-598
11. Banker GS, Anderson NR. Tablets. In: Lachman L, Lieberman HA, Kanig JL, editors. The Theory and Practice of Industrial Pharmacy. 3rd ed. Mumbai: Varghese Publishing House; 1987. p. 293-299
12. Goodhart FW, Draper JR, Dancz D, Ninger FC. Evaluation of tablet breaking strength testers. J Pharm Sci 1973;62:297.
13. Mahajan HS, Kuchekar BS, Badhan AC. Mouth dissolving tablets of sumatriptan succinate. Indian J Pharm Sci 2004;66:238-240
14. Koizumi K. New method of preparing high porosity saliva soluble compressed tablets using mannitol with camphor. Int J Pharm 1997;152:127-131
15. Que L, Wu W, Cheng X, Hu T. Evaluation of disintegrating time of rapidly disintegrating tablets by a paddle method. Pharm Dev Technol 2006;11:295-301.
16. Indian Pharmacopoeia, Vol.2, 4th ed. New Delhi: The Controller of Publications; 1996. p. 735-736
17. Klanche J. Dissolution testing of orally disintegrating tablets. CIMA LABS INC, Dissolution Technologies; May 2003. p. 6-9.
18. The United States Pharmacopoeia-24/National Formulary-19, 2000, Asian edition. Rockville, MD: US Pharmacopoeial Convention. Inc; p. 1945-1946.
19. Shenoy V, Pandey S, Agarwal S. Optimizing fast dissolving Dosage form of Diclofenac Sodium by rapidly disintegrating agents. Indian J Pharm Sci 2003;4:197.
20. Shan-Yang L. Effect of excipients on tablet properties and dissolution behoviour of theophylene-tableted microcapsules under different compression forces. J Pharm Sci 1988;77:229-232
21. Ranga KV, Padmalatha DK, Buri P. Cellulose matrices for zero-order release of soluble drugs. Drug Develop Ind Pharm 1988;14:2299-2320
22. Keny RV, Mankame SA, Lourenco CF. Formulation and evaluation of once daily minocycline hydrochloride extended release matrix tablets. Indian J Pharm Sci 2009;71:295-302.